Dr Reddys Laboratories Share Price Today - Live Blog for March 03, 2025

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.02% upswing, and it's currently trading at ₹1,120.60 per share. Investors are closely watching this development.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.02%, reaching the current market price of ₹1,120.60. This development underscores the stock's growing popularity.

Demonstrating a commendable 0.14% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,120.50. In terms of valuation, the stock maintains a PE ratio of 18.0900, while the industry PE ratio stands at 32.7014.

The stock of Dr Reddys Laboratories Ltd suffered a -0.03% decline, and it currently trades at ₹1,118.95 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The share price of Dr Reddys Laboratories Ltd experienced a -0.16% slump and is currently trading at ₹1,118.45. While the stock maintains a PE ratio of 18.0900, the industry PE is 32.7014, raising questions about valuation.

Dr Reddys Laboratories Ltd share price has declined by -0.12%, and it's currently trading at ₹1,120.20. The stock maintains a PE of 18.0900, while the industry PE is 32.7014, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd's shares experienced a 0.23% uptick, and they are currently valued at ₹1,122.05, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1579 and an ROE of 17.3623%.

Dr Reddys Laboratories Ltd witnessed a notable 0.06% surge in its share price and is presently trading at ₹1,119.60, captivating the attention of market participants.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.13%, and as of now, it's trading at ₹1,120.00 per share. This upward trajectory is attracting keen interest from investors.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.05%, reaching the current market price of ₹1,118.60. This development underscores the stock's growing popularity.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.28%. At this moment, it's actively trading at ₹1,118.00, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd witnessed a -0.04% decrease in its share price, and it is currently trading at ₹1,114.30. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.0900, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

With a remarkable 0.09% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,114.75. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.0900, while the industry's PE ratio is 32.7014.

Dr Reddys Laboratories Ltd's stock has surged by 0.40%, and it is currently trading at ₹1,111.00. Additionally, the stock maintains a PE ratio of 18.0900, while the industry PE is 32.7014.

Dr Reddys Laboratories Ltd's stock price surged by 0.06%, reaching the current market value of ₹1,107.00 per share. This surge is a testament to the stock's recent performance.

The stock of Dr Reddys Laboratories Ltd suffered a -0.09% drop, and it's now trading at ₹1,107.45 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Following a noteworthy 0.06% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,108.45. When it comes to valuation, this stock has a PE ratio of 18.0900, with the industry PE ratio at 32.7014.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.19%, reaching a current market price of ₹1,109.55. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd share price surged by 0.09%. With its current market price standing at ₹1,110.50 per share, this stock is garnering increased attention from the investment community.

With a -0.35% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,110.40. The stock is currently trading at a PE of 18.0900, while the industry PE is 32.7014, prompting investors to assess its value proposition.

The share price of Dr Reddys Laboratories Ltd plunged by -0.03%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,115.65, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd's stock has surged by 0.09%, and it is currently trading at ₹1,115.95. Additionally, the stock maintains a PE ratio of 18.0900, while the industry PE is 32.7014.

Dr Reddys Laboratories Ltd experienced a -0.04% downturn in its share price, and it's currently trading at ₹1,112.75. This situation is generating interest among value investors who are evaluating the stock's potential.

With a -0.52% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,114.00. The stock is currently trading at a PE of 18.0900, while the industry PE is 32.7014, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd's share price rallied by 0.11%, reaching the current market price of ₹1,119.75. This surge is indicative of the stock's recent positive performance.

The stock of Dr Reddys Laboratories Ltd is facing a -0.17% decline and is currently trading at ₹1,119.55 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd observed a remarkable 0.35% surge in its share price and is presently trading at ₹1,121.55. The increased investor interest is driving this surge.